glp-1 efficacy and safety of LY3298176, a novel dual GIP and receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial Dandelion Health

Healthy longevity isnt achieved late in life

Collectively, these analyses suggest that the mesolimbic reward system may be more potently engaged with GLP-1MK-801 than semaglutide treatment

Triple-isotope tracing for pathway discernment of NMN-induced NAD + biosynthesis in whole mice

Choline deficiency can cause muscle damage, liver damage, and nonalcoholic fatty liver disease (Fischer et al

The Food and Drug Administration granted expedited approval to orforglipron, a GLP-1 drug that works like widely used injectable medications to mimic a natural hormone that controls appetite and feelings of fullness

Science and Technology Project of the Scientific Research Joint Fund for Public Hospitals in Inner Mongolia Autonomous Region (2024GLLH0321)